A comparison of the efficacy of levobupivacaine 0,125%, ropivacaine 0,125% and ropivacaine 0,2%, all combined with sufentanil 0.5 micrograms/mL, in patient-controlled epidural analgesia after hysterectomy under combined epidural and general anesthesia

eids Universitair Medisch Centrum0 个研究点目标入组 63 人开始时间: 2007年2月14日最近更新: 2012年3月19日

试验速览

暂无简介。

•Female patient > 18 years
•ASA class I-III
•Patients undergoing abdominal hysterectomy under combined epidural and general anesthesia
•Written informed consent
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Participation in a trial on investigational drugs within 3 months prior to the study
•Known hypersensitivity to amide-type local anesthetics
•Known hypersensitivity to opioids
•Known history of severe cardiovascular, hepatic, renal, respiratory, endocrinological, haematological, neurological or psychiatric disease as judged by the investigator
•Known history of peripheral neuropathies
•Those receiving chronic analgesic therapy
•Any contraindication for epidural analgesia (e.g. clotting disorders, history of lumbar surgery)
•Inability to perform VAS score
•Pregnancy or lactation
•Any other reason which in the opinion of the investigator makes the patient unsuitable for participation in the study

发起方